Neurointervention.  2021 Mar;16(1):2-5. 10.5469/neuroint.2021.00087.

Intracranial Stenting; the Current Landscape

• Kim DJ

• KMID: 2513336
• DOI: http://doi.org/10.5469/neuroint.2021.00087

Reference

1. Wabnitz A, Chimowitz M. Angioplasty, stenting and other potential treatments of atherosclerotic stenosis of the intracranial arteries: past, present and future. J Stroke. 2017; 19:271–276.

2. Wang T, Luo J, Wang X, Yang K, Jadhav V, Gao P, et al. Endovascular therapy versus medical treatment for symptomatic intracranial artery stenosis. Cochrane Database Syst Rev. 2020; (8):CD013267.

3. EC/IC Bypass Study Group. Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial. N Engl J Med. 1985; 313:1191–1200.

4. Chimowitz MI, Lynn MJ, Derdeyn CP, Turan TN, Fiorella D, Lane BF, SAMMPRIS Trial Investigators, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med. 2011; 365:993–1003.

5. Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR; Warfarin-Aspirin Symptomatic Intracranial Disease Trial Investigators. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005; 352:1305–1316.

6. Zaidat OO, Fitzsimmons BF, Woodward BK, Wang Z, Killer-Oberpfalzer M, Wakhloo A; VISSIT Trial Investigators. Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial. JAMA. 2015; 313:1240–1248.

7. Alexander MJ, Zauner A, Chaloupka JC, Baxter B, Callison RC, Gupta R, WEAVE Trial Sites and Interventionalists, et al. WEAVE trial: final results in 152 on-label patients. Stroke. 2019; 50:889–894.

8. Alexander MJ, Zauner A, Gupta R, Alshekhlee A, Fraser JF, Toth G, et al. The WOVEN trial: wingspan one-year vascular events and neurologic outcomes. J Neurointerv Surg. 2020; doi: 10.1136/ neurintsurg-2020-016208.

9. Wabnitz AM, Derdeyn CP, Fiorella DJ, Lynn MJ, Cotsonis GA, Liebeskind DS; SAMMPRIS Investigators. Hemodynamic markers in the anterior circulation as predictors of recurrent stroke in patients with intracranial stenosis. Stroke. 2018; doi:10.1161/STROKEAHA.118.020840.

10. Alexander MJ. Response by Alexander et al to letter regarding article, “WEAVE trial: final results in 152 on-label patients”. Stroke. 2019; 50:e223.

11. Kasner SE, Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS; Warfarin Aspirin Symptomatic Intracranial Disease Trial Investigators. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation. 2006; 113:555–563.

12. Turan TN, Maidan L, Cotsonis G, Lynn MJ, Romano JG, Levine SR; Warfarin-Aspirin Symptomatic Intracranial Disease Investigators. Failure of antithrombotic therapy and risk of stroke in patients with symptomatic intracranial stenosis. Stroke. 2009; 40:505–509.

13. Fiorella D, Derdeyn CP, Lynn MJ, Barnwell SL, Hoh BL, Levy EI; SAMMPRIS Trial Investigators. Detailed analysis of periprocedural strokes in patients undergoing intracranial stenting in stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS). Stroke. 2012; 43:2682–2688.

14. Lutsep HL, Barnwell SL, Larsen DT, Lynn MJ, Hong M, Turan TN; SAMMPRIS Investigators. Outcome in patients previously on antithrombotic therapy in the SAMMPRIS trial: subgroup analysis. Stroke. 2015; 46:775–779.

15. Derdeyn CP, Chimowitz MI, Lynn MJ, Fiorella D, Turan TN, Janis LS; Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial Investigators. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial. Lancet. 2014; 383:333–341.

16. Yu W, Jiang WJ. Stenting for intracranial stenosis: potential future for the prevention of disabling or fatal stroke. Stroke Vasc Neurol. 2018; 3:140–146.

17. Baek JH, Kim BM, Heo JH, Kim DJ, Nam HS, Kim YD. Outcomes of endovascular treatment for acute intracranial atherosclerosis-related large vessel occlusion. Stroke. 2018; 49:2699–2705.

18. Cui XP, Lin M, Mu JS, Ye JX, He WQ, Fu ML, et al. Angioplasty and stenting for patients with symptomatic intracranial atherosclerosis: study protocol of a randomised controlled trial. BMJ Open. 2016; 6:e012175.

19. Gao P, Zhao Z, Wang D, Wu J, Cai Y, Li T, et al. China angioplasty and stenting for symptomatic intracranial severe stenosis (CASSISS): a new, prospective, multicenter, randomized controlled trial in China. Interv Neuroradiol. 2015; 21:196–204.